Antibody-Drug Conjugates

GettyImages/AlexRaths

ADCs: Global service demand buoyed by approvals, WuXi

By Dan Stanton

Antibody-drug conjugates (ADCs) are one of the “hottest areas of research” says STA Pharmaceutical and WuXi Biologics which are investing in conjugation and fill/finish capabilities in China.

GettyImages/urfinguss

Daiichi Sankyo inks Glycotope ADC deal

By Flora Southey

Daiichi Sankyo Company has signed an option agreement to develop Glycotope’s antibody drug conjugate (ADC) to target various cancers including ovarian, lung and breast tumours.

Follow us

Products

View more

Webinars